Published in Hepatitis Weekly, October 23rd, 2006
Study 1: A study from Italy has documented the effects of interferon plus ribavirin treatment on nuclear-factor kB (NF-kappa B), transforming growth factor beta-1 (TGF-beta 1), and metalloproteinase activity in chronic hepatitis C.
"Little is known about the cellular and molecular mechanisms underlying the effects of anti-viral therapy on the regression of liver inflammation and fibrosis in chronic hepatitis C," wrote M. Guido and colleagues, University of Verona.
They continued, "The aim of this study was to evaluate the effects of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.